五洲医疗
(301234)
| 流通市值：5.36亿 | | | 总市值：19.78亿 |
| 流通股本：1841.21万 | | | 总股本：6800.00万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 104,080,066.71 | 477,428,734.79 | 342,595,211.54 | 212,130,611.53 |
| 营业收入 | 104,080,066.71 | 477,428,734.79 | 342,595,211.54 | 212,130,611.53 |
| 二、营业总成本 | 98,335,641.9 | 432,845,398.2 | 308,997,749.91 | 189,106,063.48 |
| 营业成本 | 88,862,963.34 | 392,455,482.97 | 283,091,808.79 | 175,449,986.11 |
| 税金及附加 | 1,018,479.71 | 3,371,894.2 | 2,454,713.65 | 1,543,032.57 |
| 销售费用 | 2,894,358.03 | 14,089,035.52 | 7,858,474.67 | 5,750,866.37 |
| 管理费用 | 4,115,757.24 | 18,967,171.07 | 12,286,929.05 | 7,392,456.68 |
| 研发费用 | 2,593,757.78 | 12,969,676.77 | 8,424,760.48 | 5,005,219.26 |
| 财务费用 | -1,149,674.2 | -9,007,862.33 | -5,118,936.73 | -6,035,497.51 |
| 其中:利息费用 | 6,334.72 | 18,970.11 | 7,460.94 | 3,808.67 |
| 其中:利息收入 | 447,279.4 | 3,849,279.19 | -3,336,257.67 | -2,691,040.41 |
| 加:公允价值变动收益 | -992,693.77 | 895,111.14 | 62,650.6 | -244,194.34 |
| 加:投资收益 | 1,957,122.75 | 1,837,475.76 | 1,740,896.22 | 1,082,642.12 |
| 资产处置收益 | - | 14,153.22 | 14,153.22 | 14,153.22 |
| 资产减值损失(新) | -1,483,338.84 | -3,069,610.6 | -2,158,056.28 | -2,006,385.72 |
| 信用减值损失(新) | 619,563.87 | -2,210,327.71 | -737,263.41 | -336,920.14 |
| 其他收益 | 1,157,650.03 | 4,881,091.53 | 8,354,861.38 | 4,686,648.28 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 7,002,728.85 | 46,931,229.93 | 40,874,703.36 | 26,220,491.47 |
| 加:营业外收入 | 27,424.24 | 140,429.92 | 4,153.82 | 50 |
| 减:营业外支出 | 311,020.51 | 616,706.69 | 661,134.21 | 485,777.71 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 6,719,132.58 | 46,454,953.16 | 40,217,722.97 | 25,734,763.76 |
| 减:所得税费用 | 1,084,653.24 | 6,485,142.85 | 5,882,393.61 | 3,967,293.4 |
| 六、净利润 | 5,634,479.34 | 39,969,810.31 | 34,335,329.36 | 21,767,470.36 |
| 持续经营净利润 | 5,634,479.34 | 39,969,810.31 | 34,335,329.36 | 21,767,470.36 |
| 归属于母公司股东的净利润 | 5,634,479.34 | 39,969,810.31 | 34,335,329.36 | 21,767,470.36 |
| (一)基本每股收益 | 0.08 | 0.59 | 0.5 | 0.32 |
| (二)稀释每股收益 | 0.08 | 0.59 | 0.5 | 0.32 |
| 九、综合收益总额 | 5,634,479.34 | 39,969,810.31 | 34,335,329.36 | 21,767,470.36 |
| 归属于母公司股东的综合收益总额 | 5,634,479.34 | 39,969,810.31 | 34,335,329.36 | 21,767,470.36 |
| 公告日期 | 2025-04-26 | 2025-04-19 | 2024-10-25 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |